TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 46 filers reported holding TFF PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,415 | -71.9% | 24,032 | -15.8% | 0.00% | -77.8% |
Q4 2022 | $29,979 | -73.5% | 28,547 | +2.7% | 0.01% | -75.7% |
Q3 2022 | $113,000 | -27.6% | 27,804 | +0.7% | 0.04% | -31.5% |
Q2 2022 | $156,000 | +4.0% | 27,599 | +15.7% | 0.05% | -3.6% |
Q1 2022 | $150,000 | -24.6% | 23,848 | +6.3% | 0.06% | -23.3% |
Q4 2021 | $199,000 | +25.2% | 22,435 | +9.1% | 0.07% | +4.3% |
Q3 2021 | $159,000 | -18.9% | 20,570 | +0.8% | 0.07% | -38.6% |
Q2 2021 | $196,000 | +17.4% | 20,400 | +60.6% | 0.11% | -19.1% |
Q1 2021 | $167,000 | – | 12,700 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corriente Advisors, LLC | 1,350,000 | $19,332,000 | 4.60% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 220,666 | $3,160,000 | 3.42% |
Mesirow Financial Investment Management, Inc. | 27,963 | $400,430,000 | 1.27% |
Gagnon Advisors, LLC | 176,471 | $2,527,000 | 1.14% |
PRECEPT MANAGEMENT LLC | 150,000 | $2,148,000 | 0.87% |
Nantahala Capital Management | 1,763,476 | $25,253,000 | 0.78% |
GAGNON SECURITIES LLC | 232,865 | $3,335,000 | 0.53% |
Sepio Capital, LP | 92,084 | $1,319,000 | 0.11% |
683 Capital Management, LLC | 142,024 | $2,034,000 | 0.10% |
SANDERS MORRIS HARRIS LLC | 21,326 | $394,000 | 0.09% |